Genetics of hypertrophic cardiomyopathy
- PMID: 20124998
- PMCID: PMC2932754
- DOI: 10.1097/HCO.0b013e3283375698
Genetics of hypertrophic cardiomyopathy
Abstract
Purpose of review: Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder, exhibits remarkable genetic and clinical heterogeneity. This manuscript reviews recent discoveries of disease-causing genes and their clinical consequences, and provides an overview of research that aims to elucidate how HCM ensues from a single-nucleotide mutation.
Recent findings: The spectrum of genes that are mutated in HCM has expanded. In combination with newly developed sequencing technologies, there are now robust strategies for gene-based diagnosis in HCM. Understanding the molecular pathophysiology of HCM has emerged from the study of genetically engineered animal models of disease, and new data indicate important roles for altered intracellular Ca²⁺ regulation and oxidative stress. Pharmacologic strategies to normalize these processes show promise in attenuating HCM in experimental models.
Summary: The current repertoire of HCM genes allows effective gene-based diagnosis, information that enables accurate assessment of disease risk in family members, and provides some insight into clinical course. From mechanistic insights gleaned from fundamental investigations of experimental HCM models, novel therapeutic targets that may provide new benefits for HCM patients have surfaced.
Similar articles
-
Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Ann Intern Med. 2010 Apr 20;152(8):513-20, W181. doi: 10.7326/0003-4819-152-8-201004200-00008. Ann Intern Med. 2010. PMID: 20404382 Free PMC article. Review.
-
Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.Circ J. 2019 Aug 23;83(9):1908-1916. doi: 10.1253/circj.CJ-19-0190. Epub 2019 Jul 12. Circ J. 2019. PMID: 31308319
-
Genetic Testing in Patients with Hypertrophic Cardiomyopathy.Int J Mol Sci. 2021 Sep 27;22(19):10401. doi: 10.3390/ijms221910401. Int J Mol Sci. 2021. PMID: 34638741 Free PMC article. Review.
-
Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history.Circ Res. 2011 Mar 18;108(6):743-50. doi: 10.1161/CIRCRESAHA.110.223834. Circ Res. 2011. PMID: 21415408 Free PMC article. Review.
-
Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by Genetic Research, Toward Future Therapy.Keio J Med. 2020 Dec 25;69(4):77-87. doi: 10.2302/kjm.2019-0012-OA. Epub 2020 Mar 28. Keio J Med. 2020. PMID: 32224552 Review.
Cited by
-
Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.Hum Cell. 2024 Jul;37(4):1205-1214. doi: 10.1007/s13577-024-01073-y. Epub 2024 May 18. Hum Cell. 2024. PMID: 38762696 Free PMC article.
-
Genotype-Phenotype Insights of Inherited Cardiomyopathies-A Review.Medicina (Kaunas). 2024 Mar 27;60(4):543. doi: 10.3390/medicina60040543. Medicina (Kaunas). 2024. PMID: 38674189 Free PMC article. Review.
-
Inherited Arrhythmias in the Pediatric Population: An Updated Overview.Medicina (Kaunas). 2024 Jan 3;60(1):94. doi: 10.3390/medicina60010094. Medicina (Kaunas). 2024. PMID: 38256355 Free PMC article. Review.
-
[Hypertrophic septal cardiomyopathy, the great simulator].Arch Peru Cardiol Cir Cardiovasc. 2021 Dec 31;2(4):274-278. doi: 10.47487/apcyccv.v2i4.171. eCollection 2021 Oct-Dec. Arch Peru Cardiol Cir Cardiovasc. 2021. PMID: 37727664 Free PMC article. Spanish.
-
Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.Sci Rep. 2023 Jul 12;13(1):11296. doi: 10.1038/s41598-023-38296-2. Sci Rep. 2023. PMID: 37438479 Free PMC article.
References
-
- Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–789. - PubMed
-
- Seidman JG, Seidman CE. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557–567. - PubMed
-
- Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006. - PubMed
-
- Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104–110. - PubMed
-
- Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227–2232. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous